The last podcast of 2024 sees the return of Dr Francois Feillet discussing the final results of the KAMPER study reporting long-term outcomes of Kuvan (BH4) in phenylketonuria.
https://open.spotify.com/episode/3d2y80FeohhFMkt8Gpa895?si=M79EqhPtTnysH6wSpbTU2Q
